Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

NCT05471531 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza and Pneumonia

Interventions

BIOLOGICAL: Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
BIOLOGICAL: Separate vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine

Sponsor

Sinovac Biotech Co., Ltd